A. Daruich

Discipline

Psychologie (4) Anthropologie sociale et ethnologie (1)

Type de document

Articles (20) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (16) Patients (16) Treatment (12) Eye (12) thérapie (10) Therapeutics (10) Retinal (Visual pigment) (9) Visual acuity (8) Months (8) Retinal detachment (7) Human beings (7) Surgery (6) Surgery (6) Optical coherence tomography (6) Analysis (6) analyse (5) âge (5) Case (5) Vision (5) Grammar, Comparative and general--Case (5) Epithelium (5) Case (5) Age (5) Age (5) gestion (4) Cases (4) Women (4) Rhodopsin (4) Retina (4) Management (4)

Documents écrit par A. Daruich (20) | parle de A. Daruich (0)

High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy.
E. Bousquet et al.
Phenotype of Coats disease in females.
A. Daruich et al. (2022)
Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.
A. Daruich et al.
APPLICATION OF MODIFIED NEI VFQ-25 AFTER RETINAL DETACHMENT TO VISION-RELATED QUALITY OF LIFE.
J. Potic et al. (1 mars 2021)
Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report.
C. Stathopoulos et al. (28 janv. 2020)
Levels of the oxidative stress biomarker malondialdehyde in tears of patients with central serous chorioretinopathy relate to disease activity.
A. Daruich et al. (2020)
EVOLUTION AND PATTERNS OF CHOROIDAL THICKNESS CHANGES IN RHEGMATOGENOUS RETINAL DETACHMENT.
C. Giacuzzo et al.
INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
A. Daruich et al.
Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection.
A. Daruich et al.
Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.
L. Kowalczuk et al.
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.
L. Kowalczuk et al.
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.
A. Daruich et al.
Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma: Optical Coherence Tomography Angiography Alterations Influencing Visual Acuity.
A. Matet et al. (1 août 2017)
The Eye on Mitochondrial Disorders.
J. Finsterer et al. (2016)
Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.
A. Daruich et al. (2016)
Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.
A. Daruich et al. (2016)
Sustained-release steroids for the treatment of diabetic macular edema.
A. Daruich et al. (2015)
Systemic adalimumab induces peripheral corneal infiltrates: a case report.
A. Matet et al. (2015)
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.
A. Daruich et al. (2015)
Macular dystrophy associated with the mitochondrial DNA A3243G mutation: pericentral pigment deposits or atrophy? Report of two cases and review of the literature.
A. Daruich et al. (2014)